New microwave technique could zap prostate cancer without major surgery
NCT ID NCT06128525
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early trial tested a less invasive treatment for prostate cancer called microwave ablation, which uses heat to kill tumor cells. One man with prostate cancer received the ablation before his scheduled prostate removal surgery. The goal was to see if the procedure is safe and how much tissue it kills, which could lead to a treatment that avoids major surgery and its side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- microwave ablation
- What this could lead to
- If this approach works, it could point toward a less invasive treatment for prostate cancer that avoids major surgery and its side effects.
- What could go wrong
- This was a very small, early study with only one participant, so results may not apply to others. The procedure also carries risks like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Shockwaves may speed up erectile recovery after prostate cancer surgery
- Could a common blood pressure drug help fight prostate cancer?
- Can brain waves predict bladder control after prostate surgery?
- New PET tracer could reveal hidden prostate cancer
- New PET-MRI tracer could sharpen prostate cancer biopsy accuracy
- New PET tracer could spot cancers that standard scans overlook